Back to search

Article

Chronic Lymphocytic Leukemia: Molecular Pathologies and Therapeutic Strategies

2026-04-21

Abstract excerpt

Therapy for chronic lymphocytic leukemia (CLL) has evolved dramatically with the introduction of targeted agents, particularly Bruton tyrosine kinase inhibitors (BTKis) and BCL2 inhibitors (BCL2is). This review summarizes contemporary frontline and relapsed/refractory treatment strategies, with an emphasis on molecular risk stratification, combination and triplet regimens, measurable residual disease (MRD)–guided...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ee3ec195-55bb-51eb-9dc8-a45122a25bbc
DOI
10.20944/preprints202604.1378.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Chronic Lymphocytic Leukemia: Molecular Pathologies and Therapeutic StrategiesDOI 10.20944/preprints202604.1378.v1
Select a neighboring publication to make it the new centre.